↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Czech Republic NEN contract award · ocds-ted-453468-2025-5

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu,

Fakultní nemocnice Hradec Králové awarded Kč38.7M to GlaxoSmithKline, s.r.o. for Professional Services & Consulting in July 2025 — one of 1,134 awards this buyer has made, above its typical award size.

Professional Services & Consulting
11 Jul 2025
Award date
Kč38.7M
Contract value

Buying agency

Fakultní nemocnice Hradec Králové
1,134 Awards
Kč13.9M Avg award
Above vs typical

Winning supplier

GlaxoSmithKline, s.r.o.
10 Awards
6 Buyers
Kč54.6M Total won

Contract description

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu, glofitamabu, nivolumabu a relatlimabu, panitumumabu, ramucirumabu

Premium

Related awards · Fakultní nemocnice Hradec Králové

1,134 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

1,090 more awards from this buyer · full history & CSV export

Premium

Other wins · GlaxoSmithKline, s.r.o.

10 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Fakultní nemocnice Hradec Králové and GlaxoSmithKline, s.r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up